Western blotting assay further indicated that CCL5 could induce epithelial-mesenchymal transition (EMT) in both prostate cancer cells, characterized by the decreased expression of E-cadherin as well as the increased expression of N-cadherin, Vimentin, MMP2, and MMP9 (Fig. 2d). The gene discussed is CDH2; the disease is prostate cancer.